Day: May 8, 2025

Oslo, 08 May 2025: In the first quarter, Scatec reported proportionate revenues of NOK 2.39 billion (1.23 billion), with an EBITDA of NOK 1.38 billion (0.85 billion). Scatec’s power plants generated 979 GWh in the quarter, up from 901 GWh in the same quarter last year, mainly driven by strong hydrology in the Philippines and Laos. Power production revenues were NOK 1.62 billion (1.06 billion) and EBITDA NOK 1.39 billion (0.87 billion). The increase was mainly driven by strong performance in the Philippines and gains from divestments. The Development & Construction (D&C) segment delivered revenues of NOK 0.75 billion (0.15 billion) from construction activities across South Africa, the Philippines, Tunisia, Botswana and Brazil. The gross margin remained strong at 11%. Scatec continued to deliver on its strategy to strengthen the...

Macroeconomic indicators give reason to believe that the decline in the Estonian construction market has halted and that the market is stabilizing. The Infrastructure segment is also supported this year by the volume of work related to Rail Baltica, while investments by the Transport Administration continue to decrease. In the Buildings segment, some revival can be seen in private sector orders. This stability is also reflected in the group’s results for the first quarter of 2025.As in previous years, over 90% of the group’s revenue in the first quarter of the year comes from the Buildings segment. Revenue in this segment has decreased by approximately 15% compared to the same period last year, which is also the main reason for the overall decline in the group’s revenue. During the reporting period, the group has signed a significant number...

Company announcement – No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, strengthening of organizational capabilities, and strategic partnership for petrelintide create strong foundation for accelerated growth.Entered historic and transformative partnership with Roche to co-develop and co-commercialize petrelintide as a future foundational therapy for weight management and rapidly expand into related indications, aiming to establish the leading amylin-based franchise. Enrolled the last participant in the large, global Phase 2 ZUPREME-1 trial with petrelintide in people with overweight or obesity, three months after trial initiation. Appointed Utpal Singh as Chief Scientific Officer in April 2025 to lead the next wave of differentiated and innovative...

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, reflecting continued momentum and the product’s unique position in the on-demand HAE market Joenja® (leniolisib) volume increase by 18% and revenue increased by 9% to US$10.5 million, compared to the first quarter of 2024, with accelerating patient uptake compared to the prior few quarters Operating profit, adjusted to exclude the impact of non-recurring Abliva acquisition-related expenses, amounted to US$0.8 million compared to a US$16.3 million loss in the first quarter 2024 Launched Joenja® (leniolisib) in England and Wales in April and preparing to file for U.S. FDA approval for pediatrics in the third quarter 2025 Completed the acquisition...

Lerøy Seafood Group ASA will present its results for Q1 2025 on 15 May at Continental Hotel, Stortingsgata 24/26 in Oslo at 08:00 CET. The presentation will be held in Norwegian followed by a Q&A session. Delicious seafood will be served from 07:45 CET. You may alternatively follow the Norwegian presentation and submit questions through a live broadcast available on https://www.leroyseafood.com/no/investor/ . The quarterly report and presentation will be published at 06:30 CET. A recording of the presentation in English will be available from 12:00 CET on http://www.leroyseafood.com/en/investor . This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.  

ANCHORAGE, Alaska, May 07, 2025 (GLOBE NEWSWIRE) — First National Bank Alaska’s (OTCQX:FBAK) net income for the first quarter of 2025 was $17.7 million, or $5.60 per share. This compares to a net income of $13.5 million, or $4.26 per share, for the same period in 2024. “The momentum we gained in 2024 propelled the bank to a very strong first quarter performance,” said First National Board Chair and CEO/President Betsy Lawer. “Our unrivaled 600-plus employees are delivering dynamic improvements to services across the bank. By focusing on improving our customer experiences whether in person or online, we are creating efficiencies in our operations, enhancing cybersecurity awareness and reducing the impact of fraud on the bank and our customers. Our balance sheet remains well positioned to support opportunities for Alaskans.” Loans...

(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated) VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) (“Fortuna” or the “Company”) today reported its financial and operating results for the first quarter of 2025.(Results from the Company’s San Jose Mine have been excluded from its Q1 2025 continuing results, along with the comparative figures due to the classification of the asset as held for sale as at March 31, 2025.) First Quarter 2025 Highlights Cash and CashflowRecord free cash flow1 from ongoing operations of $111.3 million in Q1, a quarter over quarter (“QoQ”) increase of 30%. QoQ free cash flow margin over sales improved to 38% from 31% Net cash from operations before working capital of $138.1 million or $0.45 per share....